Fujirebio seeks FDA nod for Lumipulse test for Alzheimer’s disease
Fujirebio’s fully automated Lumipulse G1200 system will analyse its expected in vitro diagnostic test for Alzheimer’s disease. (Credit: Business Wire)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X